Skip to contentA
Aeternum Health, Inc.
A
AETNAeternum Health, Inc. Q3 2025 · 10-Q
Revenue$8.35K$8.35K−46.0% vs Q3 2024 Net Income-$137.86K-$137.86KN/M vs Q3 2024 EPS Diluted$0.00$0.00— vs Q3 2024 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aeternum Health, Inc. · CIK 764630 · Engraved from SEC EDGAR
Operating Cash Flowderived$35,620— Margins · derivedGross margin-103.3%−6.9 pt vs Q3 2024
Operating margin-1449.3%−736.4 pt vs Q3 2024
Net margin-1652.0%−1152.1 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 13, 2025 · 44 d after period end